ERBB2 and gastric cancer: Although it remains to be fully established whether HER2 is a valid prognostic factor in gastric cancer, some studies have suggested that HER2-positivity is associated with poor outcomes and more aggressive disease [2, 5, 6, 10], whereas others have shown HER2 to be a favorable prognostic factor [11].